Skip to content

Gut Microbiota Metagenomics for Chronic Liver Disease

Research Based on Gut Microbiota Metagenomics for Prevention of Chronic Liver Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04339725
Enrollment
3240
Registered
2020-04-09
Start date
2017-04-01
Completion date
2025-01-01
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Disease Chronic

Keywords

Liver, Fecal, Gut microbiota

Brief summary

Gut microbiota modulation has effect on chronic liver disease

Detailed description

Chronic liver disease has been known as a disease of the liver which lasts over a period of 6-month. It consists of inflammation, hepatitis, cirrhosis, hepatocellular carcinoma. Gut microbiota plays an important roles in the chronic liver disease. It can suppress the progression of the liver disease by moulation gut microbiota. The investigators are still evaluating the effect of gut microbiota on the liver disease.

Interventions

Extraction fecal DNA and compare disease group to normal group

Sponsors

Chuncheon Sacred Heart Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
31 Years to 82 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 19+ * Normal : AST or ALT level \< 50IU/L, BMI \< 25 * Liver disease : AST or ATL level ≥ 50IU/L, BMI ≥ 25 * Patients hospitalized with chronic liver disease (viral hepatitis, alcoholic liver disease, non-alcoholic liver disease, cirrhosis, liver cancer)

Exclusion criteria

* Normal : AST or ATL level ≥ 50IU/L, BMI ≥ 25 * Liver disease : AST or ALT level \< 50IU/L, BMI \< 25 * If the patient refuses

Design outcomes

Primary

MeasureTime frameDescription
Fecal DNA10 yearsCompare the species and proportions of the gut microbiome
Liver enzyme10 yearsCompare the liver enzyme level
BMI10 yearsCompare the body mass index

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026